Latest filing published 13 Apr 2026 for Ginkgo Bioworks Holdings, Inc., €686k. Read the official filing
Barry Canton appears in our data through filings on Ginkgo Bioworks Holdings, Inc. shares, published by SEC (Form 4). Between 6 December 2021 and 10 April 2026, the trades on record add up to 97 filings.
The open-market record consists of 91 sales worth €17.1M, with no purchase. The rest of the record consists of 4 option exercises. 2026 to date brings no purchases and 3 sales.
The record was last updated on 13 April 2026 with an open-market sale (€686k) in Ginkgo Bioworks Holdings, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 59 declarations